Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma

Summary

RATIONALE: Biological therapies such as beta-glucan use different ways to stimulate the immune system and stop cancer cells from growing. Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. Combining beta-glucan and monoclonal antibody may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combining beta-glucan and monoclonal antibody in treating patients who have metastatic neuroblastoma.

Timeline

Start

2001-11

Primary completion

2005-01

Completion

—

Drugs

Indications